Status:
ACTIVE_NOT_RECRUITING
Prevention av Autoimmunitet Med Laktobaciller
Lead Sponsor:
Lund University
Conditions:
Celiac Disease in Children
Type 1 Diabetes
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
The incidence of autoimmune diseases (celiac disease, type 1 diabetes, thyroid disease) have increased over the past 30 years. Although most autoimmune diseases have a strong link to different risk ge...
Detailed Description
The incidence of autoimmune diseases (celiac disease, type 1 diabetes, thyroid disease) have increased over the past 30 years. Although most autoimmune diseases have a strong link to different risk ge...
Eligibility Criteria
Inclusion
- Screened persistent positive for any of the auto-antibodies associated with celiac disease (tTGa), type 1 diabetes (IAA, GADA, IA-2A, Zn-T8) and/or thyroid disease (TPOA)
Exclusion
- None
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT04014660
Start Date
October 1 2019
End Date
December 1 2025
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center (CRC), Bldng 60:11
Malmo, Sweden, 20502